Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
Authors
Keywords
-
Journal
Genome Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1186/s13073-021-00990-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
- (2021) Jason Vincent et al. Diagnostics
- CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
- (2020) Elaine Sanij et al. Nature Communications
- Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
- (2020) Kevin Litchfield et al. Cell Reports
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives
- (2020) Lucia Musacchio et al. Cancer Management and Research
- Development of a patient-derived explant model for prediction of drug responses in endometrial cancer
- (2020) Anna Collins et al. GYNECOLOGIC ONCOLOGY
- Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma
- (2019) Lorena Lazo de la Vega et al. MOLECULAR CANCER RESEARCH
- Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex
- (2019) Neylen Del Toro et al. CELL CYCLE
- Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
- (2019) K Nones et al. ANNALS OF ONCOLOGY
- Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
- (2019) Ryan M. Kahn et al. CANCER
- Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
- (2019) Felicity Newell et al. Nature Communications
- A practical guide for mutational signature analysis in hematological malignancies
- (2019) Francesco Maura et al. Nature Communications
- Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening
- (2019) Matteo Boretto et al. NATURE CELL BIOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome doubling shapes the evolution and prognosis of advanced cancers
- (2018) Craig M. Bielski et al. NATURE GENETICS
- PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
- (2018) Jianfeng Shen et al. CANCER RESEARCH
- Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
- (2018) Marthe M. de Jonge et al. CLINICAL CANCER RESEARCH
- Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression
- (2018) Charles W. Ashley et al. GYNECOLOGIC ONCOLOGY
- Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models
- (2017) Tine Cuppens et al. GYNECOLOGIC ONCOLOGY
- Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium
- (2017) Margherita Y. Turco et al. NATURE CELL BIOLOGY
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
- (2017) Nadeem Riaz et al. Nature Communications
- Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts
- (2017) Kristina A. Butler et al. NEOPLASIA
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Homologous recombination deficiency score shows superior association with outcome compared with its individual score components in platinum-treated serous ovarian cancer
- (2016) G.B. Mills et al. GYNECOLOGIC ONCOLOGY
- In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
- (2016) Mariam M. AlHilli et al. GYNECOLOGIC ONCOLOGY
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
- (2016) William J Gibson et al. NATURE GENETICS
- Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
- (2016) Siming Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
- (2015) Jeroen Depreeuw et al. GYNECOLOGIC ONCOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- (2015) J. Shen et al. Cancer Discovery
- Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
- (2014) Aki Miyasaka et al. BMC CANCER
- A Common Cancer-Associated DNA Polymerase Mutation Causes an Exceptionally Strong Mutator Phenotype, Indicating Fidelity Defects Distinct from Loss of Proofreading
- (2014) D. P. Kane et al. CANCER RESEARCH
- High Frequency ofRPL22Mutations in Microsatellite-Unstable Colorectal and Endometrial Tumors
- (2014) Ana M. Ferreira et al. HUMAN MUTATION
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
- (2014) Romana Koppensteiner et al. PLoS One
- Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
- (2014) Siân Jones et al. Nature Communications
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
- (2013) Beifang Niu et al. BIOINFORMATICS
- BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
- (2013) Y. Shen et al. CLINICAL CANCER RESEARCH
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Frequent mutations in the RPL22 gene and its clinical and functional implications
- (2012) Akiva P. Novetsky et al. GYNECOLOGIC ONCOLOGY
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
- (2012) Sarah Song et al. PLoS One
- Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer
- (2010) Cristina Bilbao et al. EUROPEAN JOURNAL OF CANCER
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays
- (2009) Tatiana Popova et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started